PM logo

Philip Morris International Inc. Stock Price

NYSE:PM Community·US$286.9b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 185 Fair Values set on narratives written by author

PM Share Price Performance

US$179.44
-3.17 (-1.74%)
US$193.14
Fair Value
US$179.44
-3.17 (-1.74%)
7.1% undervalued intrinsic discount
US$193.14
Fair Value
Price US$179.44
AnalystConsensusTarget US$193.14
AnalystHighTarget US$210.00
AnalystLowTarget US$170.00

PM Community Narratives

·
Fair Value US$193.14 7.1% undervalued intrinsic discount

PM: Share Pullback Will Present Attractive Buying Opportunity Following Guidance Update

2users have liked this narrative
0users have commented on this narrative
85users have followed this narrative
·
Fair Value US$210 14.6% undervalued intrinsic discount

Emerging Markets And Urban Growth Will Drive Smoke-Free Expansion

1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
·
Fair Value US$170 5.6% overvalued intrinsic discount

Regulatory Hurdles And Declining Demand Will Undermine Prospects

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
US$193.14
7.1% undervalued intrinsic discount
Revenue
6.12% p.a.
Profit Margin
30.92%
Future PE
24.8x
Price in 2029
US$243.07

Trending Discussion

Updated Narratives

PM logo

PM: Smoke Free Expansion And Regulatory Shift Will Drive Long-Term Upside

Fair Value: US$210 14.6% undervalued intrinsic discount
7 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
PM logo

PM: Smoke Free Outlook And FDA Shifts Will Shape Balanced Risk Profile

Fair Value: US$193.14 7.1% undervalued intrinsic discount
85 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
PM logo

PM: Regulatory Setbacks And Next Generation Execution Risks Will Temper Optimistic Outlook

Fair Value: US$170 5.6% overvalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Solid track record established dividend payer.

1 Risk
3 Rewards

Philip Morris International Inc. Key Details

US$41.5b

Revenue

US$13.6b

Cost of Revenue

US$27.9b

Gross Profit

US$16.9b

Other Expenses

US$11.1b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 22, 2026
7.10
67.28%
26.67%
-710.8%
View Full Analysis

About PM

Founded
1987
Employees
84900
CEO
Jacek Olczak
WebsiteView website
www.pmi.com

Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.

Recent PM News & Updates

Analysis Article Jun 16

Philip Morris International (PM) Stock Could Be 5.9% Undervalued After Dividend And 2026 Guidance

Philip Morris International (PM) is back in focus after reaffirming a quarterly dividend of $1.47 per share and updating its 2026 earnings guidance, as smoke-free products take a larger share of revenue. See our latest analysis for Philip Morris International. Philip Morris International’s recent dividend reaffirmation and updated 2026 earnings guidance come after a period where the share price is up 13.42% year to date, while the 5 year total shareholder return of 130.17% highlights how...
Narrative Update Jun 15

PM: Smoke Free Expansion And Regulatory Shift Will Drive Long-Term Upside

Analysts have lifted their blended price target for Philip Morris International to about $210. This reflects growing confidence in the company’s smoke free portfolio, including the planned U.S. launch of Zyn Ultra, recent IQOS developments in Japan, and expectations for an orderly CFO transition amid evolving FDA enforcement on vapes and nicotine pouches.

Recent updates

No updates